Traded Jun 3 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded May 20, 2026 · Filed May 21, 2026
Hanover Insurance's Executive Vice President sold $1.21M of Hanover Insurance shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,208,503
Shares × reported transaction price
21 days after results of Apr 29, 2026, 69 days before results of Jul 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −4.6% | +1.4% | −6.0% |
| 30 days | +3.2% | −0.2% | +3.3% |
| 90 days | +14.3% | +2.3% | +12.1% |
Past results only. Not a forecast.
Traded Jun 3 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Jun 3 · filed 1 day laterNot under a reported trading plan
Hanover Insurance's Executive Vice President sold $3.05M of Hanover Insurance shares. The filing does not indicate a pre-arranged trading plan.
Traded Jun 3 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.